Development of Inulin Acetate-Based Adjuvant

Young, Alan

Abstract

This project aims to evaluate and compare a new soluble inulin microparticle adjuvant along with approved human adjuvants alum and ISA-51VG (Seppic) in a vaccine study utilizing the companys Rift Valley Fever virus (RVFV) recombinant protein subunit vaccine. The new adjuvant may have potential commercial applications for both human and veterinary vaccines for Rift Valley Fever.

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Small Business Innovation Research – Phase I (N43)
• Project #: 272201400032C-0-0-1
• Application #: 8928415
• Project Start: 2014-09-15
• Project End: 2015-09-14
• Fiscal Year: 2014

Institution

• Name: Medgene Labs
• City: Brookings
• State: SD
• Country: United States
• Zip Code: 57006